Indian Journal of Anaesthesia  
About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions
Home | Login  | Users Online: 2601  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size    




 
CLINICAL INVESTIGATION
Year : 2009  |  Volume : 53  |  Issue : 3  |  Page : 306-311 Table of Contents     

Renal Transplantation-Anaesthetic Experience of 350 Cases


1 Clinical Associate, Department of Anaesthesia, Jaslok Hospital and Reserch Center, Mumbai, India
2 Head of the Department, Department of Anaesthesia, Jaslok Hospital and Reserch Center, Mumbai, India

Date of Web Publication3-Mar-2010

Correspondence Address:
Vaibhavi Baxi
504/Y, Jal Vaya Vihar phase 2, Sector 20,Kharghar, Navi Mumbai-410210
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20640138

Rights and PermissionsRights and Permissions
 

Transplantation provides a near normal life and excellent rehabilitation compared to dialysis and is the pre­ferred method oftreatment for end stage renal disease patients. We describe our experiences through a retrospec­tive analysis ol'anaesthesia management of 350 cases of both living related and cadaveric renal transplantation conducted between Jan 2004 -April 2008 at Jaslok Hospital And Research Center. Areas ol'our interest include preoperative patient status, fluid management, hemodynamic stability, anaesthesia management, and perioperative complications. Recent advances in surgical techniques; anaesthesia management and immunosuppressive drugs have made renal transplantation sale and predictable. Preoperative patient optimization, intraoperative physiologi­cal stability and postoperative care of'renal transplant patients have contributed to the success of'renal transplant programme in our hospital.

Keywords: Renal transplantation; End stage renal disease; General anaesthesia


How to cite this article:
Jain A, Baxi V, Dasgupta D. Renal Transplantation-Anaesthetic Experience of 350 Cases. Indian J Anaesth 2009;53:306-11

How to cite this URL:
Jain A, Baxi V, Dasgupta D. Renal Transplantation-Anaesthetic Experience of 350 Cases. Indian J Anaesth [serial online] 2009 [cited 2020 Apr 7];53:306-11. Available from: http://www.ijaweb.org/text.asp?2009/53/3/306/60294


   Introduction Top


Organ viability associated with renal transplanta­tion is a product ofthe managing ofthe donor patient, the al logralt, and the recipient patient. Short- and long­term outcome is influenced by perioperative fluid and drug treatment, and the function and viability of the trans­planted kidney seems to be optimized if graftperlusion is maximized through mild hypervolemia. At the same time careful balancing of intraoperative fluids is neces­sary against cardiovascular problems frequently en­countered in patients With uremia. Close intraoperative monitoring, optimization ofintravascular fluid volume status to maximize kidney perfusion, and prompt cor­rection of electrolyte disturbances (especially potas­sium) are key to short- and long-term success of renal transplants. [1]

We conducted a retrospective analysis of 350 cases ol'living and cadaveric renal transplants to iden­tify the trends according to patient's age, sex, cause of chronic kidney disease (CKI)), anaesthesia manage­ment and the outcome ol'patients in our hospital.


   Methods Top


In this retrospective study we reviewed medical records of 350 cases of living and cadaveric kidney trans­plants conducted from Jan 2004 -April 2008 atJaslok Hospital And Research Center, M um bai. [Figure 1] As per the hospital policy all drugs used and events that occur pen operatively were recorded manually and a copy of the preoperative assessment and anaesthesia notes written by the concerned consultant anaesthesiologist were preserved. We noted age, sex, type of transplant, cause of-CKD, preoperative status, and history oldi­alysis. Preoperative preparations and investigations, details of-anaesthesia management and monitoring and the outcome were also recorded and entered into an electronic database.

Live related donors (336 patients) belonged to ASA grade I and 2. All living donor nephrectomies; including a few laparoscopic nephrectomies were con­ducted under general anaesthesia with controlled ven­tilation. Our study though focussed on the management ofthe recepients ofrenal transplant.


   Results Top


350 patients who underwent renal transplantation at the study hospital from Jan '04 to April '08 were in the age bracket of 10 to 70yrs, with median age being 30 to 40yrs.

Of the total no.o fpatients 14 (4%) underwent cadaveric renal transplant while the rest (96%) under­went living, related renal transplant. [Figure 2].

There was predominance of male patients with 268 (76%) males and 82 females (24%).24 (6.8%) patients were pediatric. The causes ofend stage renal disease (ESRD) were chronic glomerulonephritis (CGN)-36%, chronic interstitial nephritis (GIN) 18%, diabetic nephropathy (DN)-8%, polycystic kidney dis­ease (PCKD)-7%, obstructive nephropathy (0b.N )- 6%, IGA nephropathy-6%, analgesic nephropathy (An.N)-4% and in 15% patients other causes were noted. [Figure 3].

Preoperative status

Of the 350 patients, 337 (96.3%) patients had been on hemodialysisNN while 13 (3.7%) patients had been on continuous ambulatory peritoneal dialysis (CAPD). Anemia was a common finding in most ofthe patients. Average hemoglobin (Hb) was 7.6gm% (hem atocrit­22.8). Hb was less than 7.6gm% in 18% of the pa­tients. Iron supplements were given to 85.1% patients, whi le 6% received erythropoietin and 13.1% under­went preoperative blood transfusion. Serum potassium levels were in the range of 4 - 6.8 m eq/1 with an aver­age of 4.9meq/1(±0.87SD). Serum creatinine levels were in the range of3.4 -19.1 mg/dl with an average of 9 .4m g/d1 (±3 .45SD). Electrocardiogram ofsome pa­tients had left ventricular hypertrophy (93), tall T wave (18), ST-T abnormalities (14), left atrial enlargement (9) and right bundle branch block (6). Ejection fraction was <20% in 27 patients and <30% in 59. Pericardial effusion was present in 20 patients and 7 had left ven­tricular thrombus on preoperative 2 D echo. On chest X-ray 47 patients had bilateral pleural effusion. Human leukocyte antigen (1-ILA) match between donor and recipient tissue was done in all patients.

Three-drug regimen ofimmunosupressants includ­ing methylprednisolone was used to decrease the inci­dence of graft rejection. Their use is divided in three phases -first phase of induction therapy before and during first week post transplant and involves marked immune suppression. The second phase is the mainte­nance therapy involving, drug administration continuously for three to six months to prevent acute graft rejection. They also induce tolerance. The third phase involves long-term immunosupression

maintained Ior the rest of the life. The following drugs were used for immunosupression -

Steroids, Cyclosporin, Tacrolimus, Sirolimus, Antilymphocyte globulin, Basiliximab, OKT 3 andAza­thioprine. 94% recipients were on oral anti hypertensives drugs, which Were continued on the morning of the surgery.

Anaesthesia management

General anaesthesia was the technique ol'choice in most (345) of the cases. Continuous epidural anaes­thesia with intermittent intravenous sedation was used in 5 cases.

At the study institution all living related renal transplants were done electively while cadaveric renal trans­plants were done in emergency orsemi-electively. He­modialysis was performed in almost all recipients within 24 hours before surgery to reduce the risk ofvolume overload, hyperkalemia, and excessive bleeding. Pre­medication one hour before surgery consisted of ranitidine hydrochloride 150mg orally in addition to all other medications that the patients were receiving on a regular basis.

Peripheral intravenous access was secured in the hand opposite to the functioning fistula and induction of anaesthesia was done with propolo1(2mg.kg -1 ) in 303 (86%), thiopentone(5mg.kg -1 ) in 42 (12%) and with etomidate(0.2mg.kg -1 ) in 7 (2%) patients. Neuromus­cular blockade was maintained with either atracurium [0.6mg.kg -1 ] (290), or rocuronium [0.6mg/kg] (51) orvecuronium [0.1 mg.kg -1 ] (9). All patients were intu­bated and ventilated. Anaesthesia was maintained with 40% N 2 O in oxygen supplemented with 1-2% isoflurane (276) / 1-2% sevollurane (74) with fresh gas flow of 2 l/min. Analgesia was maintained with Ientanyl 2­5mcg.kg -1 (l44) or pentazocine 0.5mg.kg -1 (153) or Morphine 0.l mg.kg -1 (53).

Intraoperative monitoring included heart rate, non­invasive blood pressure, oxygen saturation, end tidal CO2 and electrocardiogram in all patients. Central venous line was placed in the right or left internal jugu­lar vein (depending upon the presence oldialysis cath­eter) in 53 patients for central venous pressure (CVP) monitoring and in 15 patients blood pressure was moni­tored invasively. Average duration of' surgery was 5.5hrs(± 1.30S1)) and during this period intra venous fluid administered was normal saline-based crystalloid (NS, DNS) or colloid (gelofusine). 306 patients were transfused with only crystalloid while 44 patients re­ceived a combination ol'both crystalloid and colloid. 46 patients required intraoperative blood transfusion (packed cells). In the group of patients who required blood transfusion; the preoperative Hb was <7.6gm%. Intraoperatively 298 patients (85%) received injection Iurosemide average 40mg+23.09SD (1 to 1.5mg/kg).

Total ischaemia time noted was on an average 51.6 min(+ 12.29SD) with min-21 min and max of 94 min. For every one-minute ol'warm ischaemia time ten minutes of cold ischaemiatime was permitted. Kidney Would be placed in ice slush with a continuous perfu­sion ofcold saline.

Hemodynamic parameters were recorded on hourly basis from the intraoperative charting. [Figure 4] Intraoperatively dopamine infusion at 2-5 microgram/ kg was used in 40 patients. 12 patients had intraopera­tive artythmias in the form of premature ventricular con­tractions.

At the end ofthe surgery, neuromuscular block­ade was reversed with neostigmine 0.05mg/kg, and glycopyrrolate 8mcg/kg intravenously. Most ofthe pa­tients NA were extubated immediately postoperatively though recovery was delayed in 27 patients and 7 pa­tients needed postoperative ventilatory support.

Postoperative care

Patients were transferred to post kidney trans­plant care unit. Rescue analgesia was provided with tramadol (50-100m0 in 214 patients and both tramadol and pentazocine (25-30mg) in 130 patients. Epidural analgesia was used in 7 patients. Dialysis support was needed in 21 (6%) patients in the postoperative pe­riod. Acute tubular necrosis (ATN) developed in 54pa­tients, 12 developed pneumonia and 29 developed pulmonary edema. Acute grafi rejection was seen in 13 patients, which responded to thymoglobulins and imm unosupressants. Re-exploration was needed in 13 patients either for hematom a in the al louaft or for the thrombus in vessels of the graft. Heparin infusion was started in 8 patients for 3 - 5days. 6 patients under­went nephrectomy. Postoperative mortality (over six months postoperatively) of 12 patients was seen in these 350 patients. [Table 1] The rest of the patients received life-long triple drug immunosupression.


   Discussion Top


Kidney transplantation is the treatment ofchoice for patients with end-stage renal disease. [2] It is more cost effective than maintenance dialysis and usually pro­vides the patient with better quality of life. [3] Any surgical procedure, in patients with CKD has a significant increase in the perioperative morbidity and mortality. Preoperative work-up and intraoperative management of patients with end-stage organ disease are certainly among the most difficult and challenging areas in ana­esthesia. Understanding the myriad alterations in physi­ology and function, both locally and systemically, is criti­cal to providing safe and successful perioperative man­agement. Co-morbid disease is common and kequently severe in these patients.

Organ transplantation at Jaslok Hospital currently consists ofrenal and hepatic transplants. 0f these, re­nal cadaveric and living donor transplants are by far the most common. This audit shows that the renal trans­plantation programme at this institute has been success­ful. Factors responsible for good outcome are proper planning and team ellbrts by all concerned in the trans­plant team in addition to good preoperative prepara­tion of the patient. Preoperative control of the systemic effects ofCKD in recipients, well controlled intraop­erative hemodynamics, and good postoperative medi­cal care resulted in success ofthe transplant programme.

In our experience pediatric renal transplant have been associated with better outcome. This corrobo­rates with the findings from studies on pediatric trans­plants in the UK and North America [4] who have re­ported better long-term graft survival rates in children as compared to adults:

Fluid management remains a controversial sub­ject in perioperative medicine and organ transplanta­tion. Recent advances in the understanding olpharma­cokinetic and pharmacodynam ic profiles offluids, as well as transplantation physiology and pathophysioI­ogy, can guide us in new approaches to common prob­lems. Fluid therapy in transplant medicine is usually best practiced using goal-directed approaches and balanced electrolyte formulations when possible. Crystalloid so­lutions are usually preferred to correct fluid and elec­trolyte imbalance. In our study, majority o fpatients (87%) were transfused with normal saline-based crys­talloids; as most anaesthesiologists would avoid potassium containing fluids during renal transplantation, with the belief that it may worsen the hyperkalemia in the event ol'impaired graft function. However in a recent randomized, double blind study comparing Ringer's solution and 0.9% normal saline during renal transplant the authors have shown those who received Ringer's solution had less hyperkalemia and acidosis. The saline infusion leads to acidosis possibly by dilution of bicar­bonate by large volumes ol'buffer free fluid or the re­sultant hyperchloremia decreases the strong ion differ­ence with the development of acidosis. The hyperchloremic metabolic acidosis leads to hyperkale­mia by shilt of potassium into extracellular space. How­ever in this study the average volume ofcrystal loid in­fused during the surgery was about 6 litres. [6]

Both crystalloids and colloids have been used Ibr volume replacement. Over the last few decades there has been a shift in practice from using natural colloid to synthetic colloids. There has been some concern regard­ing the use of hydroxyethyl starch (HES) as osmotic, nephrosis-like lesions were demonstrated in transplanted kidneys retrieved from deceased donor who were trans­fused with HES200/0.62 [7]. In our study 44 (12%) pa­tients received a combination ofcrvstalloids and colloids with the colloid being mainly gelatin based. Some fluids may exert drub effects that could alter organ preserva­tion and reperfusion, while the low molecular weight HES appears to be less toxic in renal transplantation than first suspected, especially when clinicians consider free wa­ter requirements in these settings. [8]

Standard ASA monitors Were used in all the patients, however in patients with more advanced stages of co-morbid conditions, more extensive monitoring such as CVP monitoring (53patients) or continuous arterial pressure monitoring (15patients) were used. Inotropic support was used in 40 patients. No major rise in blood pressure was seen in these patients. In a large series ofrenal transplantation by Heino H and Orko R hypotension (49%) was a more common find­ing than hypertension (26.8%). [9]

A retrospective study ofpostoperative respira­tory morbidity in 247 patients requiring renal transplan­tation showed that 7 patients required postoperative controlled ventilation. Long acting non-depolarising relaxants were used in only 65 patients, but all 7 cases ofrespiratory failure occurred in this group, which sug­gests that the use of these drugs in anephric patients is potentially hazardous so Tar as postoperative respira­tory insufficiency is concerned. [10] In an other study by Avner Sidi and Richard Kaplan, prolonged neuromus­cular blockade has been reported in 8 out of 65 pa­tients of renal transplant who had received either Vecuronium(4 Out of 29) or atracurium(4 out of 36). [11] In our study too neuromuscular blockade was main­tained with either atracurium (290) or rocuroni um (5 1) or vecuronium (9). Persistent neuromuscular blockade with delayed recovery was seen in 27 patients and 7 patients needed postoperative ventilatory support. In our study only S cases were done using continuous epidural anaesthesia with intermittent intravenous se­dation. No major complication was reported in either ol'these cases. There have been reports of renal trans­plants done under continuous epidural anesthesia with intermittent sedation with intravenous agents by Lauretti, Gabriela Rocha. They also reported frequent respira­tory complications and intraoperative rupture of the renal anastomosis due to cough, hiccups and agitation. As an alternative technique, the laryngeal mask airway (LMA) was used to maintain clear upper airways dur­ing continuous epidural anesthesia. [12]

Transplant anaesthesia is a specialized field, which requires a good understanding ofthe abnormalities in patients with renal failure, familiarity with transplant medicine and expertise in management ol ' these patients. With improvement in anaesthetic and surgical techniques as well as immunosuppressive drugs, many patients are being accepted for transplantation who would have been considered unsuitable earlier. Proper patient selection, preoperative patient preparation and intraoperative physiological stability with close association between nephrologist, urosurgeons and anaesthesiologists have found a valuable place in the management ofour renal transplant patients and has given us good results. Fur­ther large scales studies are desired.



 
   References Top

1.Sprung J, Kapural L, Bourke DL, O'Hare JF Jr. Anesthe-sia for kidney transplant surgery. Anesthasiol Clin North America. 2000;18:919-51.  Back to cited text no. 1      
2.Lemmens HJ. Kidney transplantation: recent develop­ents and recommendations for anesthetic management.Anesthiol Clin North America, 2004;22:651-62.  Back to cited text no. 2      
3.Evans RW, Manninea DL, Garrison LP, et al. The quality of life of patients with end-stage renal disease. N Eng J Med 1985;312:553.  Back to cited text no. 3      
4.Postlethwaite R.I. Johnson RJ, Armstrong, S,et al. The outcome of cadaveric renal transplantation in the UK and Eire. Pediatr Transplant 2002; 6: 367-77.5.  Back to cited text no. 4      
5.Elshihabi 1, Chavars B, Donaldson L, et al. Continuing improvement in cadaveric graft survival in North Ameri­can children. The 1998 Annual report of the North Ameri­can Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2000; 4: 235-46.  Back to cited text no. 5      
6.O'Malley CMN. Frumento RJ, Hardy MA, et al. A ran­domized double blind comparision of lactated Ringer's solution and 0.9% NaCl during renal transplantation. Anesthsia Analgesia 2006;100:1518-24.  Back to cited text no. 6      
7.Cittanova ML, Leblanc I. Legendre C, et al. Effect of hydroxyethyl starch in brain dead kidney donors on renal function in kidney transplant recipients. Lancet 1996;348:1620-1622.  Back to cited text no. 7      
8.Roche, Anthony M. James, Michael FM. Fluid therapy in organ transplantation. Current Opinion in Organ Transplantation.2007; 12:281-286.  Back to cited text no. 8      
9.Heino H, Orko R. Rosenberg PH. Anaesthesiological problems in renal transplantation: A retrospective study of 500 transplantations. Acta Anaesthesiol Scand 1986;30:574-580.  Back to cited text no. 9      
10.Rouse J M. Galley R L A, Bevan D R. Prolonged curarisation following renal transplantation. A retrospec­tive study. Anaesthesia 1977:32 :247-251 .  Back to cited text no. 10      
11.Sidi A, Kaplan R. Davis R.Prolonged neuromuscular blockade and ventilatory failure after renal transplanta­tion and cyclosporine. Can. J Anesth19903 7:543-8.  Back to cited text no. 11      
12.Lauretti, Rocha 0, Garcia, Vicente L. Use of laryngeal mask airway during continuous epidural anesthesia for renal transplant. Rev.bras. anesthiol. 1996;46:107-113.  Back to cited text no. 12      


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Introduction
    Methods
    Results
    Discussion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed3777    
    Printed77    
    Emailed1    
    PDF Downloaded840    
    Comments [Add]    

Recommend this journal